102 related articles for article (PubMed ID: 11880553)
21. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet.
Bladbjerg EM; Marckmann P; Sandström B; Jespersen J
Thromb Haemost; 1994 Jun; 71(6):755-8. PubMed ID: 7974344
[TBL] [Abstract][Full Text] [Related]
22. Postprandial coagulation activation in overweight individuals after weight loss: acute and long-term effects of a high-monounsaturated fat diet and a low-fat diet.
Bladbjerg EM; Larsen TM; Due A; Jespersen J; Stender S; Astrup A
Thromb Res; 2014 Mar; 133(3):327-33. PubMed ID: 24369828
[TBL] [Abstract][Full Text] [Related]
23. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
24. Plasma concentrations of blood coagulation factor VII measured by immunochemical and amidolytic methods.
Bladbjerg EM; Gram J; Jespersen J
Scand J Clin Lab Invest; 2000 May; 60(3):161-8. PubMed ID: 10885487
[TBL] [Abstract][Full Text] [Related]
25. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Carvalho de Sousa J; Azevedo J; Soria C; Barros F; Ribeiro C; Parreira F; Caen JP
Thromb Res; 1988 Jul; 51(2):165-73. PubMed ID: 3187958
[TBL] [Abstract][Full Text] [Related]
26. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia.
Cardigan RA; Crook M; Mackie IJ; Machin SJ
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):187-92. PubMed ID: 11414632
[TBL] [Abstract][Full Text] [Related]
28. FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men.
Ireland HA; Cooper JA; Drenos F; Acharya J; Mitchell JP; Bauer KA; Morrissey JH; Esnouf MP; Humphries SE
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1968-74. PubMed ID: 19696402
[TBL] [Abstract][Full Text] [Related]
29. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
30. Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart".
Mariani G; Bernardi F; Bertina R; Vicente VV; Prydz H; Samama M; Sandset PM; Di Nucci GD; Testa MG; Bendz B; Chiarotti F; Ciarla MV; Strom R
Haematologica; 1999 Jul; 84(7):620-6. PubMed ID: 10406904
[TBL] [Abstract][Full Text] [Related]
31. Postprandial lipaemia and haemostatic factors.
Miller GJ
Atherosclerosis; 1998 Dec; 141 Suppl 1():S47-51. PubMed ID: 9888642
[TBL] [Abstract][Full Text] [Related]
32. Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
Girolami A; Bertozzi I; de Marinis GB; Bonamigo E; Fabris F
Hematology; 2011 Sep; 16(5):308-12. PubMed ID: 21902896
[TBL] [Abstract][Full Text] [Related]
33. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
34. Elevation of factor VII activity and mass in coronary artery disease of varying severity.
Suzuki T; Yamauchi K; Matsushita T; Furumichi T; Furui H; Tsuzuki J; Saito H
Clin Cardiol; 1991 Sep; 14(9):731-6. PubMed ID: 1742907
[TBL] [Abstract][Full Text] [Related]
35. Activation of coagulation factor VII by tissue-type plasminogen activator.
Tsujioka H; Suehiro A; Kakishita E
Am J Hematol; 1999 May; 61(1):34-9. PubMed ID: 10331509
[TBL] [Abstract][Full Text] [Related]
36. The effect of phospholipase C on plasma factor VII.
Hubbard AR; Parr LJ
Br J Haematol; 1989 Nov; 73(3):360-4. PubMed ID: 2513868
[TBL] [Abstract][Full Text] [Related]
37. Postprandial elevation of activated factor VII in young adults.
Kapur R; Hoffman CJ; Bhushan V; Haltin MB
Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1327-32. PubMed ID: 8911270
[TBL] [Abstract][Full Text] [Related]
38. Postprandial factor VII activation does not increase plasma concentrations of prothrombin fragment 1 + 2 in patients with morbid obesity.
Landgrebe LE; Juhl CB; Andersen V; Moitinho-Silva L; Bang C; Bladbjerg EM
Thromb Res; 2020 Dec; 196():260-267. PubMed ID: 32920297
[TBL] [Abstract][Full Text] [Related]
39. Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.
Mortensen LS; Thomsen C; Hermansen K
Rev Diabet Stud; 2010; 7(3):233-40. PubMed ID: 21409315
[TBL] [Abstract][Full Text] [Related]
40. Postprandial factor VII metabolism: the effect of the R353Q and 10 bp polymorphisms.
Roche HM; Black IL; Noone E; Tully AM; Whitehead AS; Gibney MJ
Br J Nutr; 2000 May; 83(5):467-72. PubMed ID: 10953670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
